Login to Your Account

Other News To Note

Wednesday, October 12, 2011
Genesis Biopharma Inc., of Los Angeles, has entered a license agreement with the National Institutes of Health for 43 patents and patent applications relating to adoptive cell therapy with autologous tumor infiltrating lymphocytes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription